MARCHIKA MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MARCHIKA MED
Largest movements
- Receivables within one year +€28,411
up €28,411 (+278%), from €10,202 to €38,613
of which Other amounts receivable: +€16,447
- Stocks and contracts -€11,395
down €11,395 (-81.7%), from €13,950 to €2,555
- Cash -€8,751
down €8,751 (-21.9%), from €39,929 to €31,178
mainly Receivables within one year (-€28,411) and Net result for the year (-€4,191)
- Tangible fixed assets -€4,300
down €4,300 (-44.7%), from €9,625 to €5,325
- Trade debts +€4,815
up €4,815 (+24.9%), from €19,353 to €24,168
- Profit (loss) carried forward -€4,191
down €4,191 (-8.5%), from €49,353 to €45,162
- Tax, wage and social debts +€3,340
new in 2025: €3,340
- Gross operating margin -€26,119
down €26,119 (-91.8%), from €28,447 to €2,328
- Taxes -€12,778
down €12,778, from €2,804 to -€9,973
- Staff costs +€1,502
up €1,502 (+15.8%), from €9,517 to €11,019
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €73,706 | €77,671 | +€3,964 | +5.4% |
| Fixed assets | 21/28 | €9,625 | €5,325 | -€4,300 | -44.7% |
| Tangible fixed assets | 22/27 | €9,625 | €5,325 | -€4,300 | -44.7% |
| Plant, machinery and equipment | 23 | €9,625 | €5,325 | -€4,300 | -44.7% |
| Current assets | 29/58 | €64,081 | €72,346 | +€8,264 | +12.9% |
| Stocks and contracts in progress | 3 | €13,950 | €2,555 | -€11,395 | -81.7% |
| Stocks | 30/36 | €13,950 | €2,555 | -€11,395 | -81.7% |
| Amounts receivable within one year | 40/41 | €10,202 | €38,613 | +€28,411 | +278% |
| Trade receivables | 40 | €6,423 | €18,386 | +€11,963 | +186% |
| Other amounts receivable | 41 | €3,780 | €20,227 | +€16,447 | +435% |
| Cash at bank and in hand | 54/58 | €39,929 | €31,178 | -€8,751 | -21.9% |
| Total equity and liabilities | 10/49 | €73,706 | €77,671 | +€3,964 | +5.4% |
| Equity | 10/15 | €54,353 | €50,162 | -€4,191 | -7.7% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €49,353 | €45,162 | -€4,191 | -8.5% |
| Amounts payable | 17/49 | €19,353 | €27,509 | +€8,155 | +42.1% |
| Amounts payable within one year | 42/48 | €19,353 | €27,509 | +€8,155 | +42.1% |
| Trade debts | 44 | €19,353 | €24,168 | +€4,815 | +24.9% |
| Suppliers | 440/4 | €19,353 | €24,168 | +€4,815 | +24.9% |
| Taxes, remuneration and social security | 45 | - | €3,340 | +€3,340 | |
| Remuneration and social security | 454/9 | - | €3,340 | +€3,340 | |
| Remuneration, social security and pensions | 62 | €9,517 | €11,019 | +€1,502 | +15.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,300 | €4,300 | = | 0.0% |
| Other operating charges | 640/8 | €190 | - | -€190 | |
| Gross operating margin | 9900 | €28,447 | €2,328 | -€26,119 | -91.8% |
| Operating profit (loss) | 9901 | €14,441 | -€12,991 | -€27,431 | |
| Financial charges | 65/66B | €1,138 | €1,174 | +€36 | +3.1% |
| Recurring financial charges | 65 | €1,138 | €1,174 | +€36 | +3.1% |
| Profit (loss) for the period before taxes | 9903 | €13,303 | -€14,164 | -€27,467 | |
| Income taxes | 67/77 | €2,804 | -€9,973 | -€12,778 | |
| Profit (loss) for the period | 9904 | €10,498 | -€4,191 | -€14,689 | |
| Profit (loss) for the period to be appropriated | 9905 | €10,498 | -€4,191 | -€14,689 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.